Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clopidogrel - Hanmi Pharmaceutical

Next Previous
Drug Profile

Clopidogrel - Hanmi Pharmaceutical

Alternative Names: Clopidogrel napadisilate; Clopidogrel napadisilate monohydrate; Pidogul

Latest Information Update: 23 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hanmi Pharmaceutical
  • Class 2 ring heterocyclic compounds; Antiplatelets; Chlorobenzenes; Esters; Pyridines; Small molecules; Thienopyridines
  • Mechanism of Action Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Acute coronary syndromes; Myocardial infarction; Peripheral arterial disorders; Stroke

Most Recent Events

  • 10 Jan 2012 Hanmi Pharmaceutical's Clopidogrel product is available for market licensing in European Union as of 10 Jan 2012. http://www.hanmipharm.com/eng/index.asp
  • 10 Jan 2012 Registered for Acute coronary syndromes in Cyprus (PO)
  • 10 Jan 2012 Registered for Acute coronary syndromes in Germany (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top